Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.76p
   
  • Change Today:
      0.003p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 7,822,292
  • Market Cap: £23.62m
  • RiskGrade: 340

Silver Falcon agrees broad terms for Lime insurance tech acquisition

By Oliver Haill

Date: Wednesday 30 Dec 2015

LONDON (ShareCast) - (ShareCast News) - Fully listed cash shell Silver Falcon has agreed to make an initial acquisition, with a reverse takeover planned of unlisted insurance industry technology firm Lime Holdings.
Silver Falcon, which listed in November with a buy-and-build strategy focused on the 'fintech' industry, was forced to suspend its shares last week after major anticipatory spikes in its share price amid a swirl of rumours.

While the company has reached an agreement with Lime's management, the terms are subject to due diligence, a fundraising, and re-listing of the enlarged group.

Lime, which was founded in Australia but recently moved its headquarters to these shores, has developed technology for the insurance industry that enables the automated delivery of insurance to end users.

Shares in the company will remain suspended until the company is able to provide full disclosure on the deal, or when the reverse takeover takes place.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.76p
Change Today 0.003p
% Change -0.14 %
52 Week High 3.96
52 Week Low 1.17
Volume 7,822,292
Shares Issued 1,341.82m
Market Cap £23.62m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average
70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average
Price Trend
10.63% below the market average10.63% below the market average10.63% below the market average10.63% below the market average10.63% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:29 300,000 @ 1.74p
16:29 5,023 @ 1.74p
16:28 174,147 @ 1.73p
16:19 114,621 @ 1.74p
15:46 13,566 @ 1.75p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page